A Once-a-Month GLP-1? Pfizer is Working On it !

Описание: Pfizer may not be first in GLP-1s, but they are clearly not sitting this one out.

In this video, Christopher Durham breaks down what we learned directly from Pfizer’s recent analyst presentation and Q&A about their obesity strategy, including the development of a potential once-a-month GLP-1 and how the company plans to compete in a market currently led by Novo Nordisk and Eli Lilly.

This is not about hype or headlines. It is about listening carefully to what Pfizer’s executives actually said about their pipeline, their priorities, and their long-term plan in obesity care and translating what that could mean for real patients.

As part of our ongoing series looking at the earnings and analyst calls shaping the future of obesity treatment, this episode focuses on Pfizer’s position, their timeline, and the role they believe they can play in expanding access and options for patients who are using GLP-1s to treat the disease of obesity.

Christopher also shares his perspective as someone who began his GLP-1 adventure in September 2023 and has lost over 100 pounds, maintaining today at 185. Like many of you, he and Laraine have paid out of pocket for every dose. Access and affordability are not theoretical issues in this conversation. They are lived reality.

As always, Christopher is not a doctor and this video is not medical advice. If you are considering a GLP-1, speak with your healthcare provider.

If you are new to our channel, The Downsized is where we talk openly about treating the disease of obesity with GLP-1s including Zepbound, Mounjaro, Wegovy, and Ozempic and the real-world impact these medications are having on our lives.

Subscribe and follow along as we continue breaking down the strategies, decisions, and innovations that could shape the next era of obesity care.

+++++++++++++++++++++++++++++++++++++++
Get your Hume BodyPod today and use our exclusive Downsized code for up to 50% total savings! 👉 Use our Code: THEDOWNSIZED Link to purchase: https://humehealth.com//discount/THED...

Start your weight loss journey today! We use Mochi Health: https://app.joinmochi.com/eligibility...
Use Laraine’s code for $40 off: QIYGO8.

Me Again Iphone GLP-1 App: https://apps.apple.com/us/app/meagain...

AMAZON GLP-1 Companion Product Store: https://www.amazon.com/shop/downsized
As an Amazon Associate, I earn from qualifying purchases.

DOWNSIZED LINKS
Website: https://thedownsized.org
Be our guest on The Downsized Dish: apply at https://thedownsized.org/downsized-dish/
Https://Thedownsized.Org/ Book The Downsized At Sea Cruise 2026: Https://Thedownsized.Org/Downsized-At...

FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/
+++++++++++++++++++++++++++++++++++++++

00:00 Intro
01:49 Understanding the Earnings Calls
02:40 Pfizer's Market Position and Future Plans
03:13 The Importance of Obesity in Pfizer's Strategy
04:06 Pfizer's Financial Overview
08:00 The Science Behind Pfizer's GLP-1 Program
09:52 Global Market and Patient Impact
11:29 Pfizer's Broader Obesity Pipeline
15:41 Long-Term Vision and Sustainability
20:52 Conclusion and Next Steps